Indian Government become a Venture Capitalist to Pharma Industry

Published On 2015-06-29 08:19 GMT   |   Update On 2015-06-29 08:19 GMT
Advertisement

To Set up VC Fund of Rs 500 cr corpus for the pharma industry



The Indian Government is gearing up to be a venture capitalist to the Pharma industy. It plans to set up 500-crore venture capital fund to boost domestic pharma industry and provide cheaper loans to entities looking to establish or upgrade manufacturing facilities.

A task force in the deparment of pharmaceuticals ( DoP) submitted a report titled 'Recommendations of the Task Force on Enabling Private Sector to lead the growth of Pharmaceutical Industry' to the Chemicals and Fertilisers Minister Ananth Kumar. The report suggested steps to boost the pharma industry to conform with the government’s agenda of 'Make in India'
Advertisement

"Pharmaceutical Department is working on a proposal for setting up of a venture capital fund with corpus of about Rs 500 crore. Once the proposal is finalised, it will be moved to the Finance Ministry," a source told PTI.

Besides this the task force has also submitted recommendations on a scheme of soft loan and interest subsidy to help manufacturers upgrade their facilities.

The government is also working on to approve six pharma parks this year at an estimated investment of Rs 180 crore to promote pharmaceuticals manufacturing as well as setting up a mechanism for single-window clearance for the pharmaceuticals industry.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News